BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 657412)

  • 1. Metabolic fate of 2,5-dimethoxy-4-methylamphetamine in the guinea pig and rabbit.
    Nagamatsu K; Kido Y; Urakubo G
    Chem Pharm Bull (Tokyo); 1978 Apr; 26(4):1267-73. PubMed ID: 657412
    [No Abstract]   [Full Text] [Related]  

  • 2. Metabolic O-demethylation of the psychotomimetic amine 1-(2, 5-dimetroxy-4-methylphenyl)-2-aminopropane.
    Zwieg JS; Castagnoli N
    Psychopharmacol Commun; 1975; 1(4):359-71. PubMed ID: 1224005
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro O-demethylation of the psychotomimetic amine, 1-(2,5-dimethoxy-4-methylphenyl)-2-aminopropane.
    Zweig JS; Castagnoli N
    J Med Chem; 1977 Mar; 20(3):414-21. PubMed ID: 845874
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolic study of 2,5-dimethoxy-4-ethylamphetamine (DOET) in rats.
    Tansey LW; Estevez VS; Ho BT
    Proc West Pharmacol Soc; 1975; 18():362. PubMed ID: 1182040
    [No Abstract]   [Full Text] [Related]  

  • 5. In vitro stereoselective metabolism of the psychotomimetic amine, 1-(2,5-dimethoxy-4-methylphenyl)-2-aminopropane. An apparent enantiomeric interaction.
    McGraw NP; Callery SC; Castagnoli N
    J Med Chem; 1977 Feb; 20(2):185-9. PubMed ID: 836489
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Studies on chiral interactions of 1-(2,5-dimethoxy-4-methylphenyl)-2-aminopropane and the corresponding N-hydroxy metabolites with cytochrome P-450.
    McGraw NP; Castagnoli N
    J Med Chem; 1981 Mar; 24(3):299-304. PubMed ID: 7265116
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Studies on radioimmunoassay for 2,5-dimethoxy-4-methylamphetamine.
    Nagamatsu K; Kido Y; Urakabo G
    Chem Pharm Bull (Tokyo); 1977 Dec; 25(12):3390-4. PubMed ID: 564751
    [No Abstract]   [Full Text] [Related]  

  • 8. Chemical and biological studies of 1-(2,5-dihydroxy-4-methylphenyl)-2-aminopropane, an analogue of 6-hydroxydopamine.
    Jacob P; Kline T; Castagnoli N
    J Med Chem; 1979 Jun; 22(6):662-71. PubMed ID: 458821
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monomethylthio analogues of 1-(2,4,5-trimethoxyphenyl)-2-aminopropane.
    Jacob P; Anderson G; Meshul CK; Shulgin AT; Castagnoli N
    J Med Chem; 1977 Oct; 20(10):1235-9. PubMed ID: 903913
    [TBL] [Abstract][Full Text] [Related]  

  • 10. N-Hydroxylation of 1-(2,5-demethoxy-4-methylphenyl)-2-aminopropane by rabbit liver microsomes.
    Gal J; Gruenke LD; Castagnoli N
    J Med Chem; 1975 Jul; 18(7):683-8. PubMed ID: 1151987
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolism of N-alkylating derivatives of amphetamine by guinea pig and rabbit liver homogenates.
    Coutts RT; Jones GR; Liu SF
    Proc West Pharmacol Soc; 1982; 25():119-23. PubMed ID: 7122485
    [No Abstract]   [Full Text] [Related]  

  • 12. Potent agonist activity of DOB at 5-HT2 receptors in guinea pig trachea.
    Heller WA; Baraban JM
    Eur J Pharmacol; 1987 Jun; 138(1):115-7. PubMed ID: 3622603
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 2,5-Dimethoxyamphetamine-derived designer drugs: studies on the identification of cytochrome P450 (CYP) isoenzymes involved in formation of their main metabolites and on their capability to inhibit CYP2D6.
    Ewald AH; Maurer HH
    Toxicol Lett; 2008 Dec; 183(1-3):52-7. PubMed ID: 18938231
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Studies on the identification of psychotropic substances. VI. Preparation and various analytical data of reference standards of some hallucinogens, 2,5-dimethoxy-4-methylamphetamine (STP), 2,5-dimethoxy-4-bromoamphetamine (DOB) and 2,5-dimethoxy-4-ethylamphetamine (DOET)].
    Shimamine M; Takahashi K; Nakahara Y
    Eisei Shikenjo Hokoku; 1989; (107):113-9. PubMed ID: 2636911
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of delta9-tetrahydrocannabinol & 2, 5-dimethoxy-4-methylamphetamine on rat sexual dominance behavior.
    Uyeno ET
    Proc West Pharmacol Soc; 1976; 19():369-72. PubMed ID: 996008
    [No Abstract]   [Full Text] [Related]  

  • 16. Selectivity of serotonergic drugs for multiple brain serotonin receptors. Role of [3H]-4-bromo-2,5-dimethoxyphenylisopropylamine ([3H]DOB), a 5-HT2 agonist radioligand.
    Titeler M; Lyon RA; Davis KH; Glennon RA
    Biochem Pharmacol; 1987 Oct; 36(19):3265-71. PubMed ID: 3663239
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The behavioral effects of 2,5-dimethoxy-4-alkyl amphetamines.
    Morin RD; Benington F; Mitchell SR; Beaton JM; Bradley RJ; Smythies JR
    Experientia; 1975 Jan; 31(1):93-5. PubMed ID: 234850
    [No Abstract]   [Full Text] [Related]  

  • 18. 3H-DOB (4-bromo-2,5-dimethoxyphenylisopropylamine) labels a guanyl nucleotide-sensitive state of cortical 5-HT2 receptors.
    Lyon RA; Davis KH; Titeler M
    Mol Pharmacol; 1987 Feb; 31(2):194-9. PubMed ID: 3543649
    [TBL] [Abstract][Full Text] [Related]  

  • 19. (R)-(-)-[77Br]4-bromo-2,5-dimethoxyamphetamine labels a novel 5-hydroxytryptamine binding site in brain membranes.
    Peroutka SJ; Hamik A; Harrington MA; Hoffman AJ; Mathis CA; Pierce PA; Wang SS
    Mol Pharmacol; 1988 Oct; 34(4):537-42. PubMed ID: 3173334
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Direct quantitative analysis of lysergic acid diethylamide (LSD) and 2, 5-dimethoxy-4-methylamphetamine (STP) on thin-layer chromatograms.
    Niwaguchi T; Inoue T
    J Chromatogr; 1976 Jun; 121(1):165-9. PubMed ID: 932131
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.